Thus, the here described sensitivity of PDAC cancer cells to ferroptosis suggests an alternative pathway to selectively kill pancreatic cancer cells, especially considering that mutationally-active KRas mutations drive the majority of PDAC [7, 53, 54]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.